Drugs & Pharmaceuticals M&A » By The Online Investor Staff, updated Sat., Mar. 25, 1:44 PM
Recent mergers and acquisitions in the Drugs & Pharmaceuticals M&A category.
| This Slide: #26 of 100 |
Slide #26. Perrigo Company plc — OTC Products In Australia
Acquirer:
Perrigo Company plc (NYSE:PRGO)
Acquiree:
OTC Products In Australia
Details:
Perrigo Company plc (NYSE: PRGO;TASE) announced that it has acquired a basket of value-brand OTC products sold in Australia and New Zealand from Aspen Global Inc. for $51 million in cash. The products are primarily sold through the mass retail channel and include the Herron range of analgesics, vitamins and supplements. This basket of products is expected to generate at least $20 million in annual revenue.
Perrigo is a provider of over-the-counter health and wellness solutions that can be self-managed. Co.'s segments are as follows: Consumer Self-Care Americas, which is focused primarily on the sale of self-care products in categories including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements; Consumer Self-Care International, which develops, manufactures, markets, and distributes European consumer self-care brands in the upper respiratory, pain and sleep-aids, digestive health, vitamins, minerals and supplements; and Prescription Pharmaceuticals, which develops, manufactures, and markets a portfolio of generic prescription drugs.
PRGO SEC Filing Email Alerts Service
Open the PRGO Page at The Online Investor »
|
|||||||||||||||||||||
Open the PRGO Page at The Online Investor (in a new window) »
 Free PRGO Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
Avg. Broker Rec.
 
|
Strong Buy (3.83 out of 4) 71st percentile
(ranked higher than approx. 71% of all stocks covered)
Analysts' Target Price: PRGO Stock Forecast Based on Zacks ABR data; powered by Xignite |
